 In mice and nonhuman primate studies Neumega has shown potent thrombopoietic activity in compromised hematopoiesis, including moderately to severely myelosuppressed animals.In these studies, Neumega improved platelet nadirs and accelerated platelet recoveries compared to controls.In animal studies Oprelvekin also has non-hematopoetic activities.